BCI
TERN

Brinker Capital Investments’s Terns Pharmaceuticals TERN Stock Holding History

Brinker Capital Investments’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$762K Buy
+14,451
New +$594K 0.01% 1265
2025
Q1 		– Sell
-22,211
Closed -$123K – 1978
2024
Q4 		$123K Buy
+22,211
New +$150K ﹤0.01% 1784

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Brinker Capital Investments's TERN Position: Q1 2026 in Review

Brinker Capital Investments opened a new position in Terns Pharmaceuticals (TERN) in Q1 2026: 14,451 shares worth $762K. The stake represents 0.01% of the portfolio and ranks #1265 among its holdings. This is a return to the name: Brinker Capital Investments previously reported a position in TERN as recently as Q4 2024.

Brinker Capital Investments first reported a position in TERN in Q4 2024 and has held it in 2 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Brinker Capital Investments held 14,451 shares of Terns Pharmaceuticals worth $762K as of Q1 2026.
  • Terns Pharmaceuticals was a new Brinker Capital Investments position in Q1 2026.
  • Terns Pharmaceuticals made up 0.01% of Brinker Capital Investments's portfolio in Q1 2026, its #1265 holding.
  • Brinker Capital Investments first reported a position in Terns Pharmaceuticals in Q4 2024 and has held it in 2 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.